© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 15, 1143-1150,
August 7, 2002
© 2002 Oxford University Press
ARTICLE |
Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer
Affiliations of authors: T. Whelan, M. Levine, McMaster University, and Cancer Care Ontario (CCO) Hamilton Regional Cancer Centre, Hamilton, Ontario; R. MacKenzie, CCO Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario; J. Julian, B. Szechtman, McMaster University, Hamilton, Ontario; W. Shelley, CCO Kingston Regional Cancer Centre, Kingston, Ontario; L. Grimard, CCO Ottawa Regional Cancer Centre, Ottawa, Ontario; B. Lada, CCO Northeastern Ontario Regional Cancer Centre, Sudbury, Ontario; H. Lukka, CCO Hamilton Regional Cancer Centre; F. Perera, CCO London Regional Cancer Centre, London, Ontario; A. Fyles, Princess Margaret Hospital, Toronto, Ontario; E. Laukkanen, CCO Windsor Regional Cancer Centre, Windsor, Ontario; S. Gulavita, CCO Northwestern Ontario Regional Cancer Centre; V. Benk, McGill University, Montreal, Quebec, Canada.
Correspondence to: Timothy Whelan, B.M., B.Ch., M.Sc., Hamilton Regional Cancer Centre, 699 Concession St., Hamilton, ON L8V 5C2, Canada (e-mail: tim.whelan{at}hrcc.on.ca).
Background: Breast irradiation after lumpectomy is an integral component of breast-conserving therapy that reduces the local recurrence of breast cancer. Because an optimal fractionation schedule (radiation dose given in a specified number of fractions or treatment sessions over a defined time) for breast irradiation has not been uniformly accepted, we examined whether a 22-day fractionation schedule was as effective as the more traditional 35-day schedule in reducing recurrence. Methods: Women with invasive breast cancer who were treated by lumpectomy and had pathologically clear resection margins and negative axillary lymph nodes were randomly assigned to receive whole breast irradiation of 42.5 Gy in 16 fractions over 22 days (short arm) or whole breast irradiation of 50 Gy in 25 fractions over 35 days (long arm). The primary outcome was local recurrence of invasive breast cancer in the treated breast. Secondary outcomes included cosmetic outcome, assessed with the European Organisation for Research and Treatment of Cancer (EORTC) Cosmetic Rating System. All statistical tests were two-sided. Results: From April 1993 through September 1996, 1234 women were randomly assigned to treatment, 622 to the short arm and 612 to the long arm. Median follow-up was 69 months. Five-year local recurrence-free survival was 97.2% in the short arm and 96.8% in the long arm (absolute difference = 0.4%, 95% confidence interval [CI] = –1.5% to 2.4%). No difference in disease-free or overall survival rates was detected between study arms. The percentage of patients with an excellent or good global cosmetic outcome at 3 years was 76.8% in the short arm and 77.0% in the long arm; the corresponding data at 5 years were 76.8% and 77.4%, respectively (absolute difference = –0.6%, 95% CI = –6.5% to 5.5%). Conclusion: The more convenient 22-day fractionation schedule appears to be an acceptable alternative to the 35-day schedule.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. C. Zellars, V. Stearns, D. Frassica, F. Asrari, T. Tsangaris, L. Myers, S. DiPasquale, J. R. Lange, L. K. Jacobs, L. A. Emens, et al. Feasibility Trial of Partial Breast Irradiation With Concurrent Dose-Dense Doxorubicin and Cyclophosphamide in Early-Stage Breast Cancer J. Clin. Oncol., June 10, 2009; 27(17): 2816 - 2822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Buchholz Radiation Therapy for Early-Stage Breast Cancer after Breast-Conserving Surgery N. Engl. J. Med., January 1, 2009; 360(1): 63 - 70. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hiley, A. Tutt, M. Torres, and C. Palmieri Adjuvant radiotherapy for breast cancer BMJ, December 30, 2008; 337(dec30_1): a2843 - a2843. [Full Text]
|
|
|
|
|
|
J.-P. Pignol, I. Olivotto, and E. Rakovitch In Reply: J. Clin. Oncol., November 10, 2008; 26(32): 5306 - 5306. [Full Text] [PDF]
|
|
|
|
|
|
N. C Turner and A. L Jones Management of breast cancer--Part I BMJ, July 4, 2008; 337(jul04_1): a421 - a421. [Full Text]
|
|
|
|
 |
|
 R M WYATT, B J JONES, and R G DALE Radiotherapy treatment delays and their influence on tumour control achieved by various fractionation schedules Br. J. Radiol., July 1, 2008; 81(967): 549 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Osako, M. Oguchi, M. Kumada, K. Nemoto, T. Iwase, and T. Yamashita Acute Radiation Dermatitis and Pneumonitis in Japanese Breast Cancer Patients with Whole Breast Hypofractionated Radiotherapy Compared to Conventional Radiotherapy Jpn. J. Clin. Oncol., May 1, 2008; 38(5): 334 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Pignol, I. Olivotto, E. Rakovitch, S. Gardner, K. Sixel, W. Beckham, T. T. T. Vu, P. Truong, I. Ackerman, and L. Paszat A Multicenter Randomized Trial of Breast Intensity-Modulated Radiation Therapy to Reduce Acute Radiation Dermatitis J. Clin. Oncol., May 1, 2008; 26(13): 2085 - 2092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. G. Haffty, T. A. Buchholz, and B. McCormick Should Intensity-Modulated Radiation Therapy Be the Standard of Care in the Conservatively Managed Breast Cancer Patient? J. Clin. Oncol., May 1, 2008; 26(13): 2072 - 2074. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pruthi, J. C. Boughey, K. R. Brandt, A. C. Degnim, G. K. Dy, M. P. Goetz, E. A. Perez, C. A. Reynolds, P. J. Schomberg, and J. N. Ingle A Multidisciplinary Approach to the Management of Breast Cancer, Part 2: Therapeutic Considerations Mayo Clin. Proc., September 1, 2007; 82(9): 1131 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Formenti, D. Gidea-Addeo, J. D. Goldberg, D. F. Roses, A. Guth, B. S. Rosenstein, and K. J. DeWyngaert Phase I-II Trial of Prone Accelerated Intensity Modulated Radiation Therapy to the Breast to Optimally Spare Normal Tissue J. Clin. Oncol., June 1, 2007; 25(16): 2236 - 2242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Munshi and A. Budrukkar Hypofractionated Radiation Therapy in Breast Cancer: A Revolutionary Breakthrough or a Long Way to Go? J. Clin. Oncol., February 1, 2007; 25(4): 458 - 459. [Full Text] [PDF]
|
|
|
|
|
|
A. T. Schroen, D. R. Brenin, M. D. Kelly, W. A. Knaus, and C. L. Slingluff Jr Impact of Patient Distance to Radiation Therapy on Mastectomy Use in Early-Stage Breast Cancer Patients J. Clin. Oncol., October 1, 2005; 23(28): 7074 - 7080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Whelan Use of Conventional Radiation Therapy As Part of Breast-Conserving Treatment J. Clin. Oncol., March 10, 2005; 23(8): 1718 - 1725. [Full Text] [PDF]
|
|
|
|
|
|
J. Wright, L. Fairclough, J. Manzo, L. Phippard, B. Smuck, and J. Lacourciere The Metrics of Clinical Trials J. Clin. Oncol., March 1, 2005; 23(7): 1589 - 1590. [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Bucci, A. Bevan, and M. Roach III Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond CA Cancer J Clin, March 1, 2005; 55(2): 117 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ragaz, I. A. Olivotto, J. J. Spinelli, N. Phillips, S. M. Jackson, Kenneth. S. Wilson, M. A. Knowling, C. M. L. Coppin, L. Weir, K. Gelmon, et al. Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial J Natl Cancer Inst, January 19, 2005; 97(2): 116 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Whelan and M. Levine Radiation Therapy and Tamoxifen: Concurrent or Sequential? That Is the Question J. Clin. Oncol., January 1, 2005; 23(1): 1 - 4. [Full Text] [PDF]
|
|
|
|
|
|
V. Vinh-Hung, C. Verschraegen, M. Royce, J. Van de Steene, P. Tai, G. Cserni, G. Storme, and G. Vlastos RESPONSE: Re: Breast-Conserving Surgery With or Without Radiotherapy: Pooled-Analysis for Risks of Ipsilateral Breast Tumor Recurrence and Mortality J Natl Cancer Inst, August 18, 2004; 96(16): 1255 - 1257. [Full Text] [PDF]
|
|
|
|
|
|
T. E. Goffman and E. Glatstein Hypofractionation Redux? J. Clin. Oncol., February 15, 2004; 22(4): 589 - 591. [Full Text] [PDF]
|
|
|
|
|
|
P. Wallner, D. Arthur, H. Bartelink, J. Connolly, G. Edmundson, A. Giuliano, N. Goldstein, J. Hevezi, T. Julian, R. Kuske, et al. Workshop on Partial Breast Irradiation: State of the Art and the Science, Bethesda, MD, December 8-10, 2002 J Natl Cancer Inst, February 4, 2004; 96(3): 175 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. N. Coleman, P. E. Wallner, and J. S. Abrams Inflammatory Breast Issue J Natl Cancer Inst, August 20, 2003; 95(16): 1182 - 1183. [Full Text] [PDF]
|
|
|
|
|
|
R. G. Pearcey and A. W. Lees Re: Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer J Natl Cancer Inst, May 21, 2003; 95(10): 759 - 759. [Full Text] [PDF]
|
|
|
|
|
|
T. Whelan and M. Levine RESPONSE: Re: Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer J Natl Cancer Inst, May 21, 2003; 95(10): 759 - 759. [Full Text] [PDF]
|
|
|
|
|
|
T. Whelan, M. Levine, and J. Julian Re: Is Less More? Lessons in Radiation Schedules in Breast Cancer J Natl Cancer Inst, May 7, 2003; 95(9): 685 - 686. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Whelan, I. Olivotto, and M. Levine Clinical practice guidelines for the care and treatment of breast cancer: breast radiotherapy after breast-conserving surgery (summary of the 2003 update) Can. Med. Assoc. J., February 18, 2003; 168(4): 437 - 439. [Full Text] [PDF]
|
|
|
|
|
|
C. I. Sartor and J. E. Tepper Is Less More? Lessons in Radiation Schedules in Breast Cancer J Natl Cancer Inst, August 7, 2002; 94(15): 1114 - 1115. [Full Text] [PDF]
|
|